A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,826 shares of STRO stock, worth $84,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,826
Previous 30,913 45.01%
Holding current value
$84,272
Previous $90,000 72.22%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.88 - $5.01 $40,069 - $69,704
13,913 Added 45.01%
44,826 $155,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $90,265 - $164,766
30,913 New
30,913 $90,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $98.1M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.